{"id":175729,"date":"2022-08-10T06:45:05","date_gmt":"2022-08-10T06:45:05","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=175729"},"modified":"2022-08-10T06:45:05","modified_gmt":"2022-08-10T06:45:05","slug":"langerhans-cell-histiocytosis","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/","title":{"rendered":"Langerhans cell Histiocytosis"},"content":{"rendered":"<p>A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any organ system including the skeleton may be involved. These diseases were previously given names such as histiocytosis X, Hand-Schiiller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Treatment may consist of surgical removal of bone lesions and radiation therapy for lesions threatening vital functions such as sight and hearing. Corticosteroids or cytotoxic agents are useful in controlling soft-tissue disease and multiple skeletal lesions. Bone marrow transplantation has been used in recurrent and progressive Langerhans\u2019 cell histiocytosis.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":["post-175729","post","type-post","status-publish","format-standard","hentry","category-l"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Langerhans cell Histiocytosis - Definition of Langerhans cell Histiocytosis<\/title>\n<meta name=\"description\" content=\"A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any organ system including the skeleton may be involved. These diseases were previously given names such as histiocytosis X, Hand-Schiiller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Treatment may consist of surgical removal of bone lesions and radiation therapy for lesions threatening vital functions such as sight and hearing. Corticosteroids or cytotoxic agents are useful in controlling soft-tissue disease and multiple skeletal lesions. Bone marrow transplantation has been used in recurrent and progressive Langerhans\u2019 cell histiocytosis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Langerhans cell Histiocytosis - Definition of Langerhans cell Histiocytosis\" \/>\n<meta property=\"og:description\" content=\"A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any organ system including the skeleton may be involved. These diseases were previously given names such as histiocytosis X, Hand-Schiiller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Treatment may consist of surgical removal of bone lesions and radiation therapy for lesions threatening vital functions such as sight and hearing. Corticosteroids or cytotoxic agents are useful in controlling soft-tissue disease and multiple skeletal lesions. Bone marrow transplantation has been used in recurrent and progressive Langerhans\u2019 cell histiocytosis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-10T06:45:05+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/\",\"name\":\"Langerhans cell Histiocytosis - Definition of Langerhans cell Histiocytosis\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-08-10T06:45:05+00:00\",\"dateModified\":\"2022-08-10T06:45:05+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any organ system including the skeleton may be involved. These diseases were previously given names such as histiocytosis X, Hand-Schiiller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Treatment may consist of surgical removal of bone lesions and radiation therapy for lesions threatening vital functions such as sight and hearing. Corticosteroids or cytotoxic agents are useful in controlling soft-tissue disease and multiple skeletal lesions. Bone marrow transplantation has been used in recurrent and progressive Langerhans\u2019 cell histiocytosis.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Langerhans cell Histiocytosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Langerhans cell Histiocytosis - Definition of Langerhans cell Histiocytosis","description":"A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any organ system including the skeleton may be involved. These diseases were previously given names such as histiocytosis X, Hand-Schiiller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Treatment may consist of surgical removal of bone lesions and radiation therapy for lesions threatening vital functions such as sight and hearing. Corticosteroids or cytotoxic agents are useful in controlling soft-tissue disease and multiple skeletal lesions. Bone marrow transplantation has been used in recurrent and progressive Langerhans\u2019 cell histiocytosis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/","og_locale":"en_US","og_type":"article","og_title":"Langerhans cell Histiocytosis - Definition of Langerhans cell Histiocytosis","og_description":"A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any organ system including the skeleton may be involved. These diseases were previously given names such as histiocytosis X, Hand-Schiiller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Treatment may consist of surgical removal of bone lesions and radiation therapy for lesions threatening vital functions such as sight and hearing. Corticosteroids or cytotoxic agents are useful in controlling soft-tissue disease and multiple skeletal lesions. Bone marrow transplantation has been used in recurrent and progressive Langerhans\u2019 cell histiocytosis.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/","og_site_name":"Glossary","article_published_time":"2022-08-10T06:45:05+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/","name":"Langerhans cell Histiocytosis - Definition of Langerhans cell Histiocytosis","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-08-10T06:45:05+00:00","dateModified":"2022-08-10T06:45:05+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A number of clinical conditions, most commonly seen in infants and children, caused by disease of Langerhans\u2019 cell histiocytes. These cells, which are characteristic of all of the variants of the disease, cause granulomas. The great variation in the signs and symptoms produced depends upon their location and how widely spread they are. Almost any organ system including the skeleton may be involved. These diseases were previously given names such as histiocytosis X, Hand-Schiiller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Treatment may consist of surgical removal of bone lesions and radiation therapy for lesions threatening vital functions such as sight and hearing. Corticosteroids or cytotoxic agents are useful in controlling soft-tissue disease and multiple skeletal lesions. Bone marrow transplantation has been used in recurrent and progressive Langerhans\u2019 cell histiocytosis.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/langerhans-cell-histiocytosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Langerhans cell Histiocytosis"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/175729","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=175729"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/175729\/revisions"}],"predecessor-version":[{"id":175730,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/175729\/revisions\/175730"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=175729"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=175729"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=175729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}